OncoCyte Corp buy krebskrebs
Start price
15.11.21
/
50%
€2.58
Target price
15.11.22
€4.00
Performance (%)
-86.43%
End price
16.11.22
€0.35
Summary
This prediction ended on 16.11.22 with a price of €0.35. The BUY prediction by krebskrebs for OncoCyte Corp performed very badly with a performance of -86.43%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| OncoCyte Corp | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by krebskrebs for this prediction
In the thread OncoCyte Corp diskutieren
In the thread Trading OncoCyte Corp
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten